home   |   contact us   |   sitemap     

   about Formula Pharmaceuticals  technology  pipeline NewsCareers  
Top News

Media Contact  








September 18, 2017
Formula Pharmaceuticals Announces Initiation of the First Clinical Trial for Allogeneic CIK-CAR Cancer Immunotherapy

May 05, 2016
Formula Pharmaceuticals appoints Malcolm K. Brenner, MD, PhD to its Scientific Advisory Board

February 22, 2016
Formula Pharmaceuticals and Rockland Immunochemicals Enter Into a Collaboration To Develop C.I.K. CAR™ Immunotherapy Pipeline for the Treatment of Cancer

August 13, 2015
Formula Pharmaceuticals establishes Scientific Advisory Board with Leading Experts in support of Chimeric Antigen Receptor immunotherapy platform involving Cytokine Induced Killer cells

August 03, 2015
Formula Pharmaceuticals and the Max Delbrück Center for Molecular Medicine Enter Into an Exclusive Licensing Agreement and Strategic Collaboration to Develop C.I.K. CAR™ Immunotherapies

May 12, 2015
Formula Pharmaceuticals featured in BioWorld Today
"Formula One: CAR-CIK to make queasy riders of others in T-cell race?"

May 11, 2015
Formula Pharmaceuticals Acquires Next-Generation, Allogeneic, Non-Viral Chimeric Antigen Receptor (CAR) Immunotherapy Platform; Completes Private Fundraising

March 4, 2014
Formula Pharmaceuticals featured in premier investor opinion and analysis website, Seeking Alpha

October 1, 2013
Pilot clinical trial of FPI-01 initiated in patients with Multiple Myeloma following autologous stem cell transplantation

June 4, 2012
Formula Pharmaceuticals Appoints Morton Collins to Board of Directors

January 24, 2012
Formula Pharmaceuticals Appoints Martyn Greenacre to Board of Directors

December 8, 2011
Formula Pharmaceuticals featured in BioWorld Today
"Looking for Magic ‘Formula’ in Cancer Maintenance Therapy"

November 11, 2011
Formula Pharmaceuticals featured in Philadelphia Business Journal
"Duo advances a cancer-fighting Formula"

November 2010
Formula Pharma Selected As One of the Best 15 Biotech companies On East Coast to Present at BioLife 2010

October 2010
Formula Pharma Receives U.S. Government’s Qualifying Therapeutic Discovery Project (QTDP) Grant